Cambridge, UK, December 05, 2012 - Innova Biosciences, inventor of the world’s easiest to use bioconjugation kits, is pleased to announce the appointment of Dr Andrew Lane as a new Executive Director onto its Board. In addition, Tim Bernard, a non-executive director with Innova for 4 years, will become the company’s new Chairman.
Andrew has more than eighteen years’ experience in the biotechnology industry and was Managing Director of AbD Serotec in Oxford before joining Innova earlier this year. Andrew has in-depth operational experience, including manufacturing and product development, and has negotiated more than 200 licence and supply agreements with international partners, ranging from universities to major life science businesses.
Discussing the appointment Nick Gee – CEO of Innova Biosciences said ‘I’m delighted to welcome Andy onto the Board. As the company continues to expand, it is essential that we maintain a highly experienced executive team with the skills to deliver our growth objectives. Andy’s background is an ideal fit and I very much look forward to working with him.
Andrew commented – ‘I am very pleased to be joining the Board of Innova Biosciences at this exciting time in their development, and look forward to being able to contribute to their growth. The Lightning-Link® and InnovaCoat® technologies are ground-breaking and are opening up a wide range of opportunities which the company is well positioned to take advantage of’.
About Innova Biosciences Limited
Innova Biosciences is a growing, dynamic business based in Cambridge, UK. At the core of Innova's business are Lightning-Link® and InnovaCoat® technologies that simplify the production of antibody-based reagents. The expanding portfolio of products is sold to research laboratories, pharmaceutical companies, biotechnology companies and diagnostic companies worldwide. For more information, please see www.innovabiosciences.com
Algorythm Solutions Ltd
10 Torkington St, Stamford
Lincolnshire PE9 2UY
+44 (0)773 403 2112